9886.HK HKSE
Dingdang Health Technology Group Ltd.
1W: +0.0%
1M: -9.1%
3M: -14.9%
YTD: -9.1%
1Y: -3.6%
3Y: -72.6%
HK$0.80 ($0.10)
+0.00 (+0.00%)
Weekly Expected Move ±5.4%
HK$1
HK$1
HK$1
HK$1
HK$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$11M
-116.8% ▼
Capital Expenditures
$25M
-22.0% ▼
5Y CAGR: -4.3%
Free Cash Flow
-$36M
-41.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$12M
+64.1% ▲
Net Change in Cash
$32M
+228.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$901M | -$1.6B | -$1.1B | -$250M | -$376M |
| Depreciation & Amort. | $75M | $135M | $135M | $140M | $138M |
| Stock-Based Comp. | $13M | $324M | $161M | $124M | $97M |
| Change in Working Capital | -$130M | -$61M | -$140M | $5M | $15M |
| Other Non-Cash Items | $750M | $884M | $734M | -$25M | $115M |
| Operating Cash Flow | -$193M | -$295M | -$238M | -$5M | -$11M |
| — Investing Activities — | |||||
| Capital Expenditures | -$26M | -$35M | -$35M | -$14M | -$25M |
| Acquisitions (Net) | -$224M | $1M | $131K | $373K | $0 |
| Investment Purchases | -$4.1B | -$4.6B | -$7.6B | -$1.3B | $0 |
| Investment Sales | $3.8B | $5.0B | $7.3B | $1.2B | $0 |
| Other Investing | $63M | -$59M | -$27M | $150M | $182M |
| Investing Cash Flow | -$486M | $307M | -$353M | $104M | $157M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$47M | $2M | -$74M | -$82M | -$80M |
| Stock Repurchased | $0 | $0 | $0 | -$33M | -$12M |
| Dividends Paid | -$7M | $0 | $0 | $0 | $0 |
| Other Financing | $24M | -$126M | -$19M | -$15M | -$29M |
| Financing Cash Flow | $795M | $1.3B | $233M | -$131M | -$121M |
| Net Change in Cash | $116M | $1.3B | -$342M | -$25M | $32M |
| Cash End of Period | $309M | $1.9B | $1.5B | $1.2B | $1.2B |
| Free Cash Flow | -$246M | -$408M | -$265M | -$26M | -$36M |